Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jiangsu Hengrui Medicine Co., Ltd.
  6. Summary
    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO., LTD.

(600276)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
59.22 54.5 55.91 55.11 54.38 Last
46401000 81094640 52392020 53012500 48423560 Volume
-3.69% -7.97% +2.59% -1.43% -1.32% Change
Estimated financial data (e)
Sales 2021 34 368 M 5 319 M 5 319 M
Net income 2021 7 631 M 1 181 M 1 181 M
Net cash position 2021 19 829 M 3 069 M 3 069 M
P/E ratio 2021 44,7x
Yield 2021 0,38%
Sales 2022 40 810 M 6 316 M 6 316 M
Net income 2022 9 273 M 1 435 M 1 435 M
Net cash position 2022 25 179 M 3 897 M 3 897 M
P/E ratio 2022 36,9x
Yield 2022 0,44%
Capitalization 346 B 53 610 M 53 617 M
EV / Sales 2021 9,50x
EV / Sales 2022 7,87x
Nbr of Employees 28 903
Free-Float 46,5%
More Financials
Company
Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to... 
Sector
Pharmaceuticals
Calendar
08/20Earnings Release
More about the company
Ratings of Jiangsu Hengrui Medicine Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
07/01MARKET CHATTER : China Adds New Drugs to Cover Under Health Insurance Program
MT
06/24China stocks slip as healthcare firms retreat; Hong Kong up
RE
05/21Jiangsu Hengrui Pharmaceuticals Co., Ltd. Announces on Obtaining Notice of Ap..
CI
05/03Shanghai Fosun Pharmaceutical's H-Shares Surge to All-Time High
DJ
04/19Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Qua..
CI
03/15EXCLUSIVE : China's JD.com in talks to buy stake worth $1.5 billion in brokerage..
RE
03/11Jiangsu Hengrui Medicine Co., Ltd. Announces Approval of Conducting Clinical ..
CI
02/10MARKET CHATTER : Jiangsu Hengrui Medicine to Invest $20 Million in Drug Research..
MT
02/08Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Exp..
CI
2020Drugmakers agree to halve prices to get on China state insurance list
RE
2020JIANGSU HENGRUI MEDICINE : Nine-Month Net Profit Rose 14%
DJ
2020Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the Nine Mont..
CI
2020Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
2020Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
2020THERMO FISHER SCIENTIFIC : Signs Companion Diagnostic Agreement with Hengrui The..
AQ
More news
News in other languages on JIANGSU HENGRUI MEDICINE CO., LTD.
03/12SINOLINK SECURITIES : JD.com négocie son entrée au capital du courtier Sinolink
2020VALEURS MOYENNES DU BTP : Après l'arrêt total, la reprise des chantiers reste co..
More news
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration : Period :
Jiangsu Hengrui Medicine Co., Ltd. Technical Analysis Chart | 600276 | CNE0000014W7 | MarketScreener
Technical analysis trends JIANGSU HENGRUI MEDICINE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 54,38 CNY
Average target price 86,46 CNY
Spread / Average Target 59,0%
EPS Revisions
Managers and Directors
Song Zhou Chief Financial Officer
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Shuang Xue Independent Director
Qian Wang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JIANGSU HENGRUI MEDICINE CO., LTD.-41.45%53 610
JOHNSON & JOHNSON9.42%453 313
ROCHE HOLDING AG13.38%337 105
PFIZER, INC.16.30%239 637
NOVARTIS AG0.28%225 343
ELI LILLY AND COMPANY44.22%221 348